Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model

Kidney International

Volumn 84, Issue 1, 2013, Pages 78-89

  Reich, Barbara ^a   Schmidbauer, Kathrin ^a   Rodriguez Gomez, Manuel ^a   Johannes Hermann, Fabian ^a   Göbel, Nicole ^a   Brühl, Hilke ^a   Ketelsen, Isabel ^a   Talke, Yvonne ^a   Mack, Matthias ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD115 ANTIGEN; CD11B ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR2; COLLAGEN TYPE 1; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL MATURATION; CELL MIGRATION; CELLULAR DISTRIBUTION; CHIMERA; CONTROLLED STUDY; FEMALE; FIBROCYTE; KIDNEY FIBROSIS; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SPLEEN CELL; UPREGULATION; URETER OBSTRUCTION;

EID: 84879693711     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.84     Document Type: Article

References (49)

1. Bucala R, Spiegel LA, Chesney J et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1: 71-81.
2. Chesney J, Metz C, Stavitsky AB et al. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 1998; 160: 419-425.
3. Pilling D, Fan T, Huang D et al. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 2009; 4: e7475.
4. Curnow SJ, Fairclough M, Schmutz C et al. Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum. PLoS One 2010; 5: e9730.
5. Niedermeier M, Reich B, Rodriguez Gomez M et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci USA 2009; 106: 17892-17897.
6. Sakai N, Wada T, Matsushima K et al. The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes. J Hypertens 2008; 26: 780-790.
7. Hong KM, Belperio JA, Keane MP et al. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem 2007; 282: 22910-22920.
8. Shao DD, Suresh R, Vakil V et al. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 2008; 83: 1323-1333.
9. Gan Y, Reilkoff R, Peng X et al. Role of semaphorin 7a signaling in transforming growth factor beta1-induced lung fibrosis and sclerodermarelated interstitial lung disease. Arthritis Rheum 2011; 63: 2484-2494.
10. Murray LA, Chen Q, Kramer MS et al. TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. Int J Biochem Cell Biol 2011; 43: 154-162.
11. Pilling D, Roife D, Wang M et al. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol 2007; 179: 4035-4044.
12. Castano AP, Lin SL, Surowy T et al. Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo. Sci Transl Med 2009; 1: 5ra13.
13. Crawford JR, Pilling D, Gomer RH. FcgammaRI mediates serum amyloid P inhibition of fibrocyte differentiation. J Leukoc Biol 2012; 92: 699-711.
14. Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 2011; 11: 427-435.
15. Swirski FK, Nahrendorf M, Etzrodt M et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009; 325: 612-616.
16. Moore BB, Kolodsick JE, Thannickal VJ et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005; 166: 675-684.
17. Moore BB, Murray L, Das A et al. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 2006; 35: 175-181.
18. Scholten D, Reichart D, Paik YH et al. Migration of fibrocytes in fibrogenic liver injury. Am J Pathol 2011; 179: 189-198.
19. Xu J, Lin SC, Chen J et al. CCR2 mediates the uptake of bone marrowderived fibroblast precursors in angiotensin II-induced cardiac fibrosis. Am J Physiol Heart Circ Physiol 2010; 301: H538-H547.
20. Ishida Y, Kimura A, Kondo T et al. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. Am J Pathol 2007; 170: 843-854.
21. Sun L, Louie MC, Vannella KM et al. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am J Physiol Lung Cell Mol Physiol 2011; 300: L341-L353.
22. van Deventer HW, Wu QP, Bergstralh DT et al. C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. Am J Pathol 2008; 173: 253-264.
23. Sakai N, Wada T, Yokoyama H et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 2006; 103: 14098-14103.
24. Chen G, Lin SC, Chen J et al. CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol 2011; 22: 1876-1886.
25. Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006; 7: 311-317.
26. Tsou CL, Peters W, Si Y et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007; 117: 902-909.
27. Kitagawa K, Wada T, Furuichi K et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 2004; 165: 237-246.
28. Nelson PJ, Rees AJ, Griffin MD et al. The renal mononuclear phagocytic system. J Am Soc Nephrol 2012; 23: 194-203.
29. Broekema M, Harmsen MC, van Luyn MJ et al. Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J Am Soc Nephrol 2007; 18: 165-175.
30. Hashimoto N, Jin H, Liu T et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004; 113: 243-252.
31. Galligan CL, Fish EN. Circulating fibrocytes contribute to the pathogenesis of arthritis. Arthritis Rheum 2012; 64: 3583-3593.
32. Schmidt M, Sun G, Stacey MA et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003; 171: 380-389.
33. Chu PY, Mariani J, Finch S et al. Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol 2010; 176: 1735-1742.
34. Fernando R, Atkins S, Raychaudhuri N et al. Human fibrocytes coexpress thyroglobulin and thyrotropin receptor. Proc Natl Acad Sci USA 2012; 109: 7427-7432.
35. Mathai SK, Gulati M, Peng X et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest 2010; 90: 812-823.
36. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009; 27: 669-692.
37. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82.
38. Sunderkotter C, Nikolic T, Dillon MJ et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004; 172: 4410-4417.
39. Bruhl H, Cihak J, Plachy J et al. Targeting of Gr-1+,CCR2+ monocytes in collagen-induced arthritis. Arthritis Rheum 2007; 56: 2975-2985.
40. Mack M, Cihak J, Simonis C et al. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol 2001; 166: 4697-4704.
41. Arnold L, Henry A, Poron F et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007; 204: 1057-1069.
42. Yrlid U, Jenkins CD, MacPherson GG. Relationships between distinct blood monocyte subsets and migrating intestinal lymph dendritic cells in vivo under steady-state conditions. J Immunol 2006; 176: 4155-4162.
43. Daley JM, Thomay AA, Connolly MD et al. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 2008; 83: 64-70.
44. Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 2010; 6: 643-656.
45. Grande MT, Lopez-Novoa JM. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 2009; 5: 319-328.
46. Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010; 21: 1819-1834.
47. Boring L, Gosling J, Chensue SW et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997; 100: 2552-2561.
48. Duffield JS, Forbes SJ, Constandinou CM et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005; 115: 56-65.
49. Lin SL, Castano AP, Nowlin BT et al. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 2009; 183: 6733-6743.